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Summary and Conclusions
MR (magnetic resonance) imaging has proven to be a very sensitive diagnostic
tool for the detection of cerebral lesions such as tumor metastases. These malignant
lesions are currently depicted on account of their blood-brain barrier disruption and
increased water content. However, the images lack specificity and it is often
difficult to make a clear discrimination between neoplastic tissue and associated
edema, i.e. water accumulation in the surrounding tissue due to leakage through the
disrupted bbb. The diagnostic sensitivity of MR imaging in the detection of tumors
may be improved by specific contrast enhancement. This can be effectuated by
selective targeting of a MR contrast agent using specific immunological carriers,
which is the subject of this thesis.
In Chapter 1, an introduction on this thesis is given. The dependency of signal
intensity in MR imaging on the T, and ?, relaxation times is explained, and the
currently available MR contrast agents and their capabilities to alter tissue contrast
are described. It is also discussed how monoclonal antibodies and liposomes may be
used as selective delivery vehicles. Furthermore, primary brain tumors and tumors
metastatic to the brain are discussed in view of the disrupted blood-brain barrier
@bb) associated with these malignant tissues.
In Chapter 2, various iron-oxide containing compounds were assessed as a
potential MR contrast agent. Dextran-magnetite particles (DMP) clearly proved to
have superior relaxation properties, predominantly affecting T2, wrd were therefore
selected for further study. The in vivo biodistribution after i.v. injection was
assessed for the brain, kidney and liver in rats. It was found that DMP was rapidly
and predominantly taken up by liver Kupffer cells. It appeared however, also that
the particles were able to localize in those areas of the brain where the bbb was
experimentally disrupted. To this end, a freezing injury to the rat cerebral cortex
was used as a model of bbb-disruption. The presence of DMP in the blood
circulation and the liver could be easily detected in MR imaging as a result of the
strong decrease of signal intensity.
In Chapter 3, DMP was further investigated for its potential in the selective
contrast-enhancement of lesions with a local bbb-disruption as induced by the
frenzing injury to the cerebral cortex. The biodistribution of i.v. injected DMP was
studied using atomic absorption spectrophotometry, electron microscopy and MR
imaging. One hour after injection, focal accumulation of the particles in capillary
endothelial cells in the frenzing lesion could be demonstrated by electron
microscopy. MR imaging revealed the presence of the freezing lesion as a well
defined dark spot, resulting from the extravasation of DMP. In vivo, the relaxivity
of DMP, located in endothelial cells, was found to be signifrcantly reduced as
compared to that determined in vitro for water phantoms, probably as a result from
a more restricted diffusion of water protons. Nevertheless, it was concluded that
DMP can be used as a suitable contrast agent for the selective visualization of
cerebral lesions.
In Chapter 4, the use of monoclonal antibodies as the vehicle for selective
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delivery of DMP is described. Human peripheral blood lymphocytes (PBL's) were
chosen as a model to investigate possible monoclonal antibody (moab)-mediated
contrast enhancement of conjugated DMP. Using anti-L as a specific moab, the ln
vito labeling resulted in a strong and specific signal reduction of the PBL
suspensions, caused predominantly by a great specihc increase of R2 with a small but
significant specific increase of R,. The R, was found to decrease with increasing
freld strength. On the contrary, control experiments using MOC-31 as a non-specifrc
(control) moab did not result in a increase of R, and signal reduction. DMP-moab
conjugates therefore have great potential for the selective contrast enhancement of
target cells in MR imaging.
In Chapter 5, the use of an alternative vehicle for selective DMP delivery is
discussed. Human peripheral blood mononuclear cells (PBMNC's) were incubated
with DMP encapsulated liposomes or magnetoliposomes. It was found that DMP
could be efficiently incorporated into these cells. Electron microscopy revealed the
presence of DMP in cells mainly in phagosomes and secondary lysosomes.
DMPlabeled PBMNC's showed a strong increase of the transverse relaxation rate
(up to 16.6 s-r for 5 x 107 cells/ml) and, accordingly, a great loss of signal intensity
in MR imaging. The fraction of DMP containing PBMNC's could be enriched by
magnetic cell separation. The major population of the DMP containing celis proved
to be monocytes. When peripheral blood lymphocytes depleted of monocytes were
used for labeling, DMP uptake could also be observed in these cells. Conceivably,
the ex vivo labeling of PBMNC's with magnetoliposomes has a great potential for
the selective MR imaging of in vivo cell trafficking, e.g. in the monitoring of
lymphocyte infiltration in tumors.
In Chapter 6, an animal model is developed which may be used for the further in
vivo evaluation of the selective targeting of DMP to tumors, either by
DMP-conjugated specific moab's or by DMP-labeled tumor-infiltrating PBMNC's.
The human small cell lung carcinoma (SCLC) cell line GLC-28 was selected for
xenotransplantation i to nude rats. A subcutaneous ( .c) and two intracerebral (i.c.,
in the cerebral cortex and lateral ventricle of the brain) models of xenografted
GLC-28 tumor were established. In all the three models in vivo localization of
moab MOC-31 occurred within 4 hours after i.p. injection, with maximal binding at
24 h after injection. In addition it was noticed that a pronounced tumor infiltration of
predominantly NK cells was observed for s.c. and intraventricular xenografts, but
not for the GLC-28 tumors xenografted in the cerebral cortex. The nude ratlGLC-29
xenograft model appears to be a suitable model to investigate selective in vivo
targeting of DMP.
Finally, in Chapter 7, several aspects of the presented studies where a more
in-depth consideration was justified are elucidated. Some drawbacks which emerged
from the studies are indicated, and suggestions for further research are given.
From these investigations, it is concluded that MR imaging in combination with
the selective targeting of DMP has clinical potential for the non-invasive, improved
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